Changeflow GovPing Pharma & Drug Safety Philips Azurion Interventional Radiology Recall...
Priority review Enforcement Amended Final

Philips Azurion Interventional Radiology Recall, 847 Units

Favicon for ansm.sante.fr ANSM Drug & Device Safety Alerts
Filed
Detected
Email

Summary

ANSM has recorded safety action R2603230 regarding Philips Azurion interventional radiology systems manufactured by Philips Medical Systems Nederland BV. Affected French healthcare facilities have received direct notification from Philips. The recall encompasses 847 units of the Azurion system. Healthcare providers should immediately review their inventory and contact Philips Medical Systems for corrective action.

What changed

ANSM has recorded safety action R2603230 relating to Philips Azurion interventional radiology equipment following a manufacturer-initiated field safety corrective action. Philips Medical Systems Nederland BV has notified affected French healthcare facilities of the recall via correspondence dated 08/04/2026. The action affects 847 units of the Azurion system deployed across France.

Healthcare facilities utilizing Philips Azurion systems must review their device inventory against the recall parameters, implement any interim mitigation measures specified by Philips, and coordinate directly with the manufacturer for corrective action. Facility compliance officers should ensure clinical engineering teams are briefed, patient scheduling impacts are assessed, and all communications with ANSM and Philips are documented. Device inventory records must be updated to reflect the recall status.

What to do next

  1. Identify all Philips Azurion systems in your facility matching the recall scope
  2. Contact Philips Medical Systems Nederland BV directly for corrective action instructions
  3. Report any adverse events or device malfunctions to ANSM

Archived snapshot

Apr 8, 2026

GovPing captured this document from the original source. If the source has since changed or been removed, this is the text as it existed at that time.

A+ A-

Information n° R2603230 destinée aux services d'imagerie L'ANSM a été informée de la mise en œuvre d’une action de sécurité effectuée par la société Philips Medical Systems Nederland BV.

Les utilisateurs concernés ont reçu le courrier ci-joint.

Cette action de sécurité est enregistrée à l’ANSM sous le n° R2603230. Pour toute question, merci de vous adresser directement à l’émetteur de l’action de sécurité. Téléchargez le courrier de la société Philips Medical Systems Nederland BV (08/04/2026)

Get daily alerts for ANSM Drug & Device Safety Alerts

Daily digest delivered to your inbox.

Free. Unsubscribe anytime.

About this page

What is GovPing?

Every important government, regulator, and court update from around the world. One place. Real-time. Free. Our mission

What's from the agency?

Source document text, dates, docket IDs, and authority are extracted directly from ANSM.

What's AI-generated?

The summary, classification, recommended actions, deadlines, and penalty information are AI-generated from the original text and may contain errors. Always verify against the source document.

Last updated

Classification

Agency
ANSM
Filed
April 8th, 2026
Instrument
Enforcement
Legal weight
Binding
Stage
Final
Change scope
Substantive
Document ID
R2603230

Who this affects

Applies to
Medical device makers Healthcare providers Importers and exporters
Industry sector
3345 Medical Device Manufacturing
Activity scope
Medical device recall Field safety corrective action Device inventory review
Geographic scope
European Union EU

Taxonomy

Primary area
Medical Devices
Operational domain
Clinical Operations
Compliance frameworks
GxP
Topics
Healthcare Public Health Product Safety

Get alerts for this source

We'll email you when ANSM Drug & Device Safety Alerts publishes new changes.

Free. Unsubscribe anytime.

You're subscribed!